12/20
07:20 am
nuvb
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Low
Report
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
12/20
07:10 am
nuvb
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Low
Report
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
11/26
08:00 am
nuvb
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Low
Report
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
11/12
04:14 pm
nuvb
Nuvation Bio to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Low
Report
Nuvation Bio to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
11/12
04:05 pm
nuvb
Nuvation Bio to Present at the Jefferies London Healthcare Conference
Low
Report
Nuvation Bio to Present at the Jefferies London Healthcare Conference
11/7
12:32 pm
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its price target raised by analysts at Royal Bank of Canada from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Low
Report
Nuvation Bio Inc. (NYSE: NUVB) had its price target raised by analysts at Royal Bank of Canada from $5.00 to $6.00. They now have an "outperform" rating on the stock.
11/7
11:14 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Low
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
11/6
04:05 pm
nuvb
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
11/6
01:21 am
nuvb
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline [Yahoo! Finance]
High
Report
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline [Yahoo! Finance]
10/22
11:39 am
nuvb
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Low
Report
Nuvation Bio Inc. (NYSE: NUVB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
10/16
11:52 am
nuvb
Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? [Yahoo! Finance]
Low
Report
Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? [Yahoo! Finance]
10/16
07:51 am
nuvb
Robert Mashal At Nuvation Bio Tops Up Holding By US$220k [Yahoo! Finance]
Medium
Report
Robert Mashal At Nuvation Bio Tops Up Holding By US$220k [Yahoo! Finance]
10/7
04:32 pm
nuvb
Nuvation Bio names Philippe Sauvage CFO [Seeking Alpha]
Low
Report
Nuvation Bio names Philippe Sauvage CFO [Seeking Alpha]
10/7
04:05 pm
nuvb
Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
Low
Report
Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer